Interleukin-1 gene polymorphisms and chronic periodontitis in adult whites: A systematic review and meta-analysis

Journal of Periodontology

Volumn 83, Issue 11, 2012, Pages 1407-1419

  Karimbux, Nadeem Y ^a,e   Saraiya, Veeral M ^b   Elangovan, Satheesh ^a   Allareddy, Veerasathpurush ^a   Kinnunen, Taru ^a   Kornman, Kenneth S ^c   Duff, Gordon W ^d  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Interleukin Genetics   (United States)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Genetics; Interleukin 1; Meta analysis; Periodontitis; Review; Systematic.

Indexed keywords

INTERLEUKIN 1;

ADULT; CAUCASIAN; CHRONIC PERIODONTITIS; GENETIC POLYMORPHISM; GENETICS; HUMAN; META ANALYSIS; REVIEW; RISK;

ADULT; CHRONIC PERIODONTITIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INTERLEUKIN-1; ODDS RATIO; POLYMORPHISM, GENETIC;

EID: 84868353269     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.110655     Document Type: Review

References (77)

1. Borrell LN, Burt BA, Taylor GW. Prevalence and trends in periodontitis in the USA: The [corrected] NHANES, 1988 to 2000. J Dent Res 2005;84:924-930.
2. Lindhe J, Nyman S. Long-term maintenance of patients treated for advanced periodontal disease. J Clin Periodontol 1984;11:504-514.
3. Michalowicz BS, Diehl SR, Gunsolley JC, et al. Evidence of a substantial genetic basis for risk of adult periodontitis. J Periodontol 2000;71:1699-1707.
4. Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011;117: 3720-3732.
5. Preiss DS, Meyle J. Interleukin-1 beta concentration of gingival crevicular fluid. J Periodontol 1994;65:423- 428.
6. Cavanaugh PF Jr., Meredith MP, Buchanan W, Doyle MJ, Reddy MS, Jeffcoat MK. Coordinate production of PGE2 and IL-1 beta in the gingival crevicular fluid of adults with periodontitis: Its relationship to alveolar bone loss and disruption by twice daily treatment with ketorolac tromethamine oral rinse. J Periodontal Res 1998;33:75-82.
7. Offenbacher S, Barros SP, Beck JD, Champagne CM, et al. Diagnosis of periodontal disease at the periodontal tissue-biofilm interface: Biological correlates. Oral Biosci Med 2005;213:215-220.
8. Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: The molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol 2009;27:621-668.
9. Graves DT, Cochran D. The contribution of interleukin- 1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003;74:391-401.
10. Nicklin MJ, Barton JL, Nguyen M, FitzGerald MG, Duff GW, Kornman K. A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 2002;79:718-725.
11. Pociot F, Mølvig J, Wogensen L, Worsaae H, Nerup JA. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992;22:396-402.
12. Chen H, Wilkins LM, Aziz N, et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006;15:519-529.
13. Rogus J, Beck JD, Offenbacher S, et al. IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1beta and C-reactive protein. Hum Genet 2008;123:387-398.
14. Kawaguchi Y, Tochimoto A, Hara M, et al. Contribution of single nucleotide polymorphisms of the IL1A gene to the cleavage of precursor IL-1alpha and its transcription activity. Immunogenetics 2007;59:441-448.
15. Shirodaria S, Smith J, McKay IJ, Kennett CN, Hughes FJ. Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease. J Dent Res 2000;79:1864-1869.
16. Rafiq S, Stevens K, Hurst AJ, et al. Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun 2007;8:344-351.
17. Reiner AP, Wurfel MM, Lange LA, et al. Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation. Arterioscler Thromb Vasc Biol 2008;28:1407-1412.
18. Carrol ED, Payton A, Payne D, et al. The IL1RN promoter rs4251961 correlates with IL-1 receptor antagonist concentrations in human infection and is differentially regulated by GATA-1. J Immunol 2011; 186:2329-2335.
19. El-Omar EM, Carrington M, Chow WH, et al. Interleukin- 1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
20. Persson C, Canedo P, Machado JC, El-Omar EM, Forman D. Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses. Am J Epidemiol 2011;173:259-270.
21. Iacoviello L, Di Castelnuovo A, Gattone M, et al.; IGIGI Investigators. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 2005;25:222-227.
22. Brown BD, Nsengimana J, Barrett JH, et al. An evaluation of inflammatory gene polymorphisms in sibships discordant for premature coronary artery disease: the GRACE-IMMUNE study. BMC Med 2010;8:5.
23. Loughlin J, Dowling B, Mustafa Z, Chapman K. Association of the interleukin-1 gene cluster on chromosome 2q13 with knee osteoarthritis. Arthritis Rheum 2002; 46:1519-1527.
24. Moxley G, Meulenbelt I, Chapman K, et al. Interleukin-1 region meta-analysis with osteoarthritis phenotypes. Osteoarthritis Cartilage 2010;18:200-207.
25. Attur M, Wang HY, Kraus VB, et al. Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations. Ann Rheum Dis 2010;69:856-861.
26. Aksentijevich I, Masters SL, Ferguson PJ, et al. An autoinflammatory disease with deficiency of the interleukin- 1-receptor antagonist. N Engl J Med 2009; 360:2426-2437.
27. Bresnihan B, Cobby M. Clinical and radiological effects of anakinra in patients with rheumatoid arthritis. Rheumatology (Oxford) 2003;42(Suppl. 2):ii22-ii28.
28. Hoffman HM, Throne ML, Amar NJ, et al. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies. Arthritis Rheum 2008;58:2443-2452.
29. Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, et al.; Canakinumab in CAPS Study Group. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 2009;360:2416-2425.
30. KornmanKS, CraneA,Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997;24:72-77.
31. Armitage GC, Wu Y, Wang HY, Sorrell J, di Giovine FS, Duff GW. Low prevalence of a periodontitis-associated interleukin-1 composite genotype in individuals of Chinese heritage. J Periodontol 2000;71:164-171.
32. Huynh-Ba G, Lang NP, Tonetti MS, Salvi GE. The association of the composite IL-1 genotype with periodontitis progression and/or treatment outcomes: A systematic review. J Clin Periodontol 2007;34:305-317.
33. Nikolopoulos GK, Dimou NL, Hamodrakas SJ, Bagos PG. Cytokine gene polymorphisms in periodontal disease: A meta-analysis of 53 studies including 4178 cases and 4590 controls. J Clin Periodontol 2008;35: 754-767.
34. Grigoriadou ME, Koutayas SO, Madianos PN, Strub Jr. Interleukin-1 as a genetic marker for periodontitis: Review of the literature. Quintessence Int 2010;41:517- 525.
35. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
36. Gore EA, Sanders JJ, Pandey JP, Palesch Y, Galbraith GM. Interleukin-1beta+3953 allele 2: Association with disease status in adult periodontitis. J Clin Periodontol 1998;25:781-785.
37. Wagner J, Kaminski WE, Aslanidis C, et al. Prevalence of OPG and IL-1 gene polymorphisms in chronic periodontitis. J Clin Periodontol 2007;34:823-827.
38. Egger M, Smith GW, Altman DG. Systematic Reviews in Health Care: Meta-Analysis in Context. London: BMJ Books; 2001:285.
39. Axelsson P. Role of genetic and hereditary factors. In: Diagnosis and Risk Prediction of Periodontal Diseases, vol. 3. Carol Stream, IL: Quintessence, 2002:146-163.
40. Laine ML, Farré MA, Gonzá lez G, et al. Polymorphisms of the interleukin-1 gene family, oral microbial pathogens, and smoking in adult periodontitis. J Dent Res 2001;80:1695-1699.
41. Muzzi L, Nieri M, Cattabriga M, Rotundo R, Cairo F, Pini Prato GP. The potential prognostic value of some periodontal factors for tooth loss: A retrospective multilevel analysis on periodontal patients treated andmaintained over 10 years. J Periodontol 2006;77: 2084-2089.
42. Nieri M, Muzzi L, Cattabriga M, Rotundo R, Cairo F, Pini Prato GP. The prognostic value of several periodontal factors measured as radiographic bone level variation: A 10-year retrospective multilevel analysis of treated and maintained periodontal patients. J Periodontol 2002;73:1485-1493.
43. McGuire MK, Nunn ME. Prognosis versus actual outcome. IV. The effectiveness of clinical parameters and IL-1 genotype in accurately predicting prognoses and tooth survival. J Periodontol 1999;70:49-56.
44. Galbraith GM, Hendley TM, Sanders JJ, Palesch Y, Pandey JP. Polymorphic cytokine genotypes asmarkers of disease severity in adult periodontitis. J Clin Periodontol 1999;26:705-709.
45. McDevitt MJ, Wang HY, Knobelman C, et al. Interleukin- 1 genetic association with periodontitis in clinical practice. J Periodontol 2000;71:156-163.
46. Ehmke B, Kress W, Karch H, Grimm T, Klaiber B, Flemmig TF. Interleukin-1 haplotype and periodontal disease progression following therapy. J Clin Periodontol 1999;26:810-813.
47. Meisel P, Siegemund A, Dombrowa S, Sawaf H, Fanghaenel J, Kocher T. Smoking and polymorphisms of the interleukin-1 gene cluster (IL-1alpha, IL-1beta, and IL-1RN) in patients with periodontal disease. J Periodontol 2002;73:27-32.
48. Meisel P, SiegemundA,GrimmR, et al. The interleukin-1 polymorphism, smoking, and the risk of periodontal disease in the population-based SHIP study. J Dent Res 2003;82:189-193.
49. Eickholz P, Kaltschmitt J, Berbig J, Reitmeir P, Pretzl B. Tooth loss after active periodontal therapy. 1: Patientrelated factors for risk, prognosis, and quality of outcome. J Clin Periodontol 2008;35:165-174.
50. Konig J, Ruhling A, Plagmann HC, Meisel P, Kocher T. Influence of interleukin (IL)-1 composite genotype on clinical variables in non-smoking, well-maintained compliant patients with chronic periodontitis. Swed Dent J 2005;29:11-16.
51. Cullinan MP, Westerman B, Hamlet SM, et al. A longitudinal study of interleukin-1 gene polymorphisms and periodontal disease in a general adult population. J Clin Periodontol 2001;28:1137-1144.
52. Rogers MA, Figliomeni L, Baluchova K, et al. Do interleukin-1 polymorphisms predict the development of periodontitis or the success of dental implants? J Periodontal Res 2002;37:37-41.
53. López NJ, Jara L, Valenzuela CY. Association of interleukin- 1 polymorphisms with periodontal disease. J Periodontol 2005;76:234-243.
54. SakellariD,Koukoudetsos S,Arsenakis M, Konstantinidis A. Prevalence of IL-1A and IL-1B polymorphisms in a Greek population. J Clin Periodontol 2003;30:35-41.
55. Sakellari D, Katsares V, Georgiadou M, Kouvatsi A, Arsenakis M, Konstantinidis A. No correlation of five gene polymorphisms with periodontal conditions in a Greek population. J Clin Periodontol 2006;33:765-770.
56. Cattabriga M, Rotundo R, Muzzi L, et al. Retrospective evaluation of the influence of the interleukin-1 genotype on radiographic bone levels in treated periodontal patients over 10 years. J Periodontol 2001;72:767-773.
57. Kowalski J, Gó rska R, Dragan M, Kozak I. Clinical state of the patientswith periodontitis, IL-1 polymorphismand pathogens in periodontal pocket - Is there a link? (An introductory report). Adv Med Sci 2006;51(Suppl. 1): 9-12.
58. Droździk A, Kurzawski M, Safronow K, Banach J. Polymorphism in interleukin-1beta gene and the risk of periodontitis in a Polish population. Adv Med Sci 2006;51(Suppl. 1):13-17.
59. Papapanou PN, Neiderud AM, Sandros J, Dahlén G. Interleukin-1 gene polymorphism and periodontal status. A case-control study. J Clin Periodontol 2001;28: 389-396.
60. Jansson H, Lyssenko V, Gustavsson A, et al. Analysis of the interleukin-1 and interleukin-6 polymorphisms in patients with chronic periodontitis. A pilot study. Swed Dent J 2006;30:17-23.
61. Persson GR, Matuliené G, Ramseier CA, Persson RE, Tonetti MS, Lang NP. Influence of interleukin-1 gene polymorphism on the outcome of supportive periodontal therapy explored by a multi-factorial periodontal risk assessment model (PRA). Oral Health Prev Dent 2003;1:17-27.
62. Brett PM, Zygogianni P, Griffiths GS, et al. Functional gene polymorphisms in aggressive and chronic periodontitis. J Dent Res 2005;84:1149-1153.
63. Ehmke B, Beikler T, Haubitz I, Karch H, Flemmig TF. Multifactorial assessment of predictors for prevention of periodontal disease progression. Clin Oral Investig 2003;7:217-221.
64. Broad Institute. SNAP: SNP Annotation and Proxy Search. Available at: http://www.broadinstitute.org/mpg/snap/ldsearch.php. Accessed: October 15, 2011.
65. Meisel P, Schwahn C, Gesch D, Bernhardt O, John U, Kocher T. Dose-effect relation of smoking and the interleukin- 1 gene polymorphism in periodontal disease. J Periodontol 2004;75:236-242.
66. National Center for Biotechnology Information. Database of Single Nucleotide Polymorphisms (dbSNP). Available at: http://www.ncbi.nlm.nih.gov/SNP/ . dbSNP Build ID: 134. Accessed June 5, 2011.
67. AnusaksathienO, Sukboon A, Sitthiphong P, Teanpaisan R. Distribution of interleukin-1beta(+3954) and IL-1alpha (-889) genetic variations in a Thai population group. J Periodontol 2003;74:1796-1802.
68. Kobayashi T, Ito S, Kuroda T, et al. The interleukin-1 and Fcgamma receptor gene polymorphisms in Japanese patients with rheumatoid arthritis and periodontitis. J Periodontol 2007;78:2311-2318.
69. Yoshie H, Tai H, Kobayashi T, et al. Salivary enzyme levels after scaling and interleukin-1 genotypes in Japanese patients with chronic periodontitis. J Periodontol 2007;78:498-503.
70. Kobayashi T, Murasawa A, Ito S, et al. Cytokine gene polymorphisms associatedwith rheumatoid arthritis and periodontitis in Japanese adults. J Periodontol 2009;80: 792-799.
71. Duan H, Zhang J, Zhang Y. The association between IL-1 gene polymorphisms and susceptibility to severe periodontitis (in Chinese). Hua Xi Kou Qiang Yi Xue Za Zhi 2002;20:48-51.
72. Zhong L, Zhang Y, Zhang J, Yang A, Huang H. The association of interleukin-1 gene polymorphisms with the susceptibility to chronic periodontitis in Uighur (in Chinese). Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002; 19:405-408.
73. Huang HY, Zhang JC. Investigation on the association of interleukin-1 genotype polymorphism with chronic periodontitis (in Chinese). Hua Xi Kou Qiang Yi Xue Za Zhi 2004;22:415-419.
74. Corleto VD, PagniniC,MargagnoniG, et al. IL-1beta-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: An Italian population study and meta-analysis of European studies. Dig Liver Dis 2010;42:179-184.
75. Trust W; Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-678.
76. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009; 461:747-753.
77. Gouda HN, SagooGS, Harding AH, Yates J, SandhuMS, Higgins JP. The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: A HuGE review and meta-analysis. Am J Epidemiol 2010;171:645-655.